Integrating molecular docking and network pharmacology to reveal the molecular mechanisms of Anemarrhena asphodeloides in the treatment of non-small cell lung cancer

首页 > 成果 > 详情

认领

导出

Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Xie, Xianshun;Jiang, Yiling;Liu, Sumei;Xie, Changjun

通讯作者：

Xie, CJ;Liu, SM

作者机构：

[Xie, Xianshun; Xie, Changjun] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Oncol Hematol, Hengyang 421001, Hunan, Peoples R China.

[Jiang, Yiling] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Oncol, Hengyang, Hunan, Peoples R China.

[Liu, Sumei] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Emergency, Hengyang, Hunan, Peoples R China.

通讯机构：

[Liu, SM ; Xie, CJ ] U

Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Oncol Hematol, Hengyang 421001, Hunan, Peoples R China.

Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Emergency, Hengyang, Hunan, Peoples R China.

语种：

英文

关键词：

Anemarrhena asphodeloides;Non-small cell lung cancer;Traditional Chinese medicine;Molecular docking;Network pharmacology;Experimental verification

期刊：

Discover Oncology

ISSN：

2730-6011

年：

2025

卷：

期：

页码：

1399

DOI：

10.1007/s12672-025-03178-8

基金类别：

No funding.

机构署名：

本校为第一且通讯机构

摘要：

Non-small cell lung cancer (NSCLC) is a major cause of global mortality. This study investigated Anemarrhena asphodeloides' potential mechanisms in treating NSCLC through network pharmacology and molecular docking, offering a theoretical basis for future experimental and clinical applications of traditional Chinese medicine in lung cancer therapy. Active compounds of Anemarrhena asphodeloides and their relevant targets were identified by network pharmacology methods. Key targets influenced by Anemarrhena asphodeloides in NSCLC were analyzed using the String 11.0 database to construct a PPI net...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

Integrating molecular docking and network pharmacology to reveal the molecular mechanisms of Anemarrhena asphodeloides in the treatment of non-small cell lung cancer

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问